Piet van der Slikke, CEO: "IMCD has delivered another year of significant growth which is the result of our focus on operational excellence, acquisitions and a favourable economy. Free cash flow increased by 15% to EUR 161.3 million. The acquisition of L.V. Lomas in Canada and the US is an important step in realising our strategy in this region. With Lomas we entered the Canadian market and we expanded our footprint in the US, both geographically and in important life science market segments, in particular food. In 2018 we will continue to invest in our formulation expertise and in our ICT and digital infrastructure and we will remain focused on creating an exciting company for our staff, business partners and shareholders resulting in further growth."